The global negative pressure wound therapy market reached a value of US$ 2,370 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The negative pressure wound therapy (NPWT), or vacuum-assisted closure, refers to a therapeutic technique used to treat chronic wounds, infections and burns through a vacuum dressing. It is also used for treating diabetic ulcers, pressure ulcers, skin flaps and grafts. It involves a sealed wound dressing attached to a pump that creates negative pressure in and around the wound to increase the blood flow and draw out excess fluid. This aids in the formation of granulation tissue, enhancing the blood flow and wound contraction while minimizing edema and preventing external contamination.
The increasing prevalence of chronic lifestyle disorders, such as diabetes and obesity, is one of the key factors driving the growth of the market. In line with this, the growing geriatric population, which is more susceptible to such medical ailments, is also contributing to the market growth. The rising incidences of diabetes mellitus are acting as another major growth-inducing factor. Diabetes mellitus is one of the most common causes of arterial and diabetic foot ulcers, which are treated using NPWT devices. Additionally, the increasing utilization of technologically advanced single-use NPWT devices is also providing a boost to the market growth. In comparison to the traditionally used tools, these devices are disposable, portable and highly cost-effective and can also be used for providing healthcare at home, thereby eliminating the need for prolonged hospital stays. Apart from this, the production of multi-wound NPWT devices and the development of dynamic pressure control and leak detection systems are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.
Breakup by Device:
Breakup by Component:
Breakup by Wound Type:
Breakup by Indication:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Acelity, Cardinal Health Inc., Carilex Medical Inc., ConvaTec Group PLC, Deroyal, Genadyne Biotechnologies Inc., Lohmann & Rauscher International GmbH & Co. Kg, Medela, Mölnlycke Health Care AB (A Subsidiary of Investor AB), Smith & Nephew, Talley Group, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Device, Component, Wound Type, Indication, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Acelity, Cardinal Health Inc., Carilex Medical Inc., ConvaTec Group PLC, Deroyal, Genadyne Biotechnologies Inc., Lohmann & Rauscher International GmbH & Co. Kg, Medela, Mölnlycke Health Care AB (A Subsidiary of Investor AB), Smith & Nephew, Talley Group|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at